ACER THERAPEUTICS INC. Selling, General and Administrative Expense
ACER THERAPEUTICS INC. reported Selling, General and Administrative Expense of $4.69 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-11-20
- ACER THERAPEUTICS INC. selling, general and administrative expense for the quarter ending 2023-09-30 was $4.69M, a 83.43% increase year-over-year.
- ACER THERAPEUTICS INC. selling, general and administrative expense for the quarter ending 2022-09-30 was $2.56M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 9 month |
|---|---|---|
| 2023-09-30 | $4.69M 10-Q · filed 2023-11-20 | $10.11M 10-Q · filed 2023-11-20 |
| 2022-09-30 | $2.56M 10-Q · filed 2023-11-20 | $10.07M 10-Q · filed 2023-11-20 |